Device, system, and method for transcatheter treatment of valvular regurgitation
US11759321B2 · kind B2 · utility
7Cited by
374References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 25, 2021 |
| Grant date | Sep 19, 2023 |
| Priority date | — |
| Expiry date | Jun 25, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2430/20
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Devices are disclosed for use in the transcatheter treatment of mitral valve regurgitation, specifically a coaptation assistance element for implantation across the mitral valve and an edge to edge device. Methods are disclose for reducing mitral valve regurgitation at low left ventricle pressure and high left ventricle pressure during the cardiac cycle. Devices are disclosed for use in the transcatheter treatment of mitral valve regurgitation, specifically a coaptation assistance element for implantation across the mitral valve with an adaptive coaptation element.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.